These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2903653)

  • 41. A multicentre trial of perhexiline maleate, beta-blocker and placebo in angina pectoris.
    Armstrong ML; Brand D; Emmett AJ; Hodge JL; Kellaway GS; Mestitz P; Reefman M; Wallace DC
    Med J Aust; 1974 Sep; 2(11):389-93. PubMed ID: 4154390
    [No Abstract]   [Full Text] [Related]  

  • 42. A comparison of celiprolol and propranolol in the treatment of hypertension in one hundred and seventy-nine subjects.
    Leary P; Mayol R; Capone P
    Br J Clin Pract Suppl; 1985 Jun; 40():70-2. PubMed ID: 2864068
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease.
    Fogari R; Zoppi A; Tettamanti F; Poletti L; Rizzardi G; Fiocchi G
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1145-9. PubMed ID: 1982059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmacodynamics of the new beta blockader corgard (nadolol) in patients with stress-induced angina pectoris].
    Nikolenko SA; Metelitsa VI; Nazarenko VA; Martsevich SIu; Kulikova TV
    Kardiologiia; 1984 Feb; 24(2):14-8. PubMed ID: 6143849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up.
    Kohli RS; Khurmi NS; Kardash MM; Hughes LO; Lahiri A; Raftery EB
    Eur Heart J; 1985 Oct; 6(10):845-50. PubMed ID: 2866960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Atenolol (Tenormin) in the treatment of angina pectoris].
    Haghfelt T; Pindborg T; Thayssen P
    Ugeskr Laeger; 1980 Sep; 142(38):2475-8. PubMed ID: 7003873
    [No Abstract]   [Full Text] [Related]  

  • 47. Celiprolol vs propranolol in unstable angina pectoris: a double-blind, randomized, parallel-group study.
    Cleophas TJ; van 't Leven M; Kauw FH; Remmert HP; Kuijper A; Zwinderman K
    Angiology; 1995 Feb; 46(2):137-44. PubMed ID: 7702198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and hemodynamic effects of celiprolol in essential hypertension.
    Parati G; Ravogli A; Bragato R; Omboni S; Mutti E; Mancia G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S14-21. PubMed ID: 2481785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angina pectoris: effective therapy once daily.
    Prager G
    J Int Med Res; 1979; 7(1):39-44. PubMed ID: 33863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of coronary heart disease with the beta-1-receptor blocker celiprolol in a long-term study over a 12-month period].
    Klinger D
    Wien Med Wochenschr; 1987 Jun; 137(12):278-86. PubMed ID: 2887073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
    Jones GR; Mir MA
    Br Heart J; 1981 Nov; 46(5):503-7. PubMed ID: 6119104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of bopindolol and atenolol in chronic stable angina pectoris.
    Fitscha P; Meisner W; Tiso B
    Eur J Clin Pharmacol; 1990; 38(1):81-4. PubMed ID: 1970300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Celiprolol in angina pectoris: a controlled study.
    Eff J; Godfrey J; Garutti R; Capone P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S132-4. PubMed ID: 2427843
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris.
    Salonen JT; Taskinen E; Salonen R; Seppänen K; Venäläinen J; Rauramaa R
    Am J Cardiol; 1986 Nov; 58(12):35E-40E. PubMed ID: 2878600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemodynamic interactions of a new beta blocker, celiprolol, with nifedipine in angina pectoris.
    Silke B; Verma SP; Guy S
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):681-7. PubMed ID: 1679661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Beta-blockers and nitrates in patients with peripheral arterial occlusive disease: long-term findings.
    Schweizer J; Kaulen R; Nierade A; Altmann E
    Vasa; 1997; 26(1):43-6. PubMed ID: 9068264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Celiprolol in the treatment of hypertension: a comparison with propranolol.
    Taylor SH; Beattie A; Silke B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S127-31. PubMed ID: 2427842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical pharmacology of multiple action compounds.
    Prichard BN; Tomlinson B
    Z Kardiol; 1989; 78 Suppl 3():1-6. PubMed ID: 2573211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical perspective on celiprolol: cardioprotective potential.
    Frishman WH
    Am Heart J; 1991 Feb; 121(2 Pt 2):724-9. PubMed ID: 1671192
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.
    Dorow P; Bethge H; Tönnesmann U
    Eur J Clin Pharmacol; 1986; 31(2):143-7. PubMed ID: 2879733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.